The history of the erectile dysfunction drug presents a intricate picture for investors. While the initial introduction generated massive profits, the expiration of its patent opened the floodgates to generic versions, https://getsocialsource.com/story7126103/the-copyright-and-the-pharmaceutical-industry-a-risky-bet